This seems to be the case but 30c will be a "great" deal and...

This seems to be the case but 30c will be a "great" deal and might get them more close to a YES vote and 40c will definitely. This quarterly due in a few weeks will determine if Pfizer up their bid again to the upper end, I think they will need to if ResAppDx continue the revenue uptrend from the last few quarters despite the COVID-19 result due next week. And if so, any CR to continue the COVID-19 screening development into commercialisation won't be as much were 50% can be claim on R&D rebate anyway and I thought Pfizer was offering $3M R&D independent of the T/O lol.